ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
알킬화제 시장 규모는 향후 수년간 강력한 성장이 전망됩니다. 2029년에는 CAGR 5.3%로 성장할 전망이며, 65억 7,000만 달러로 성장이 예측됩니다. 예측 기간의 성장은 암 영역의 파이프라인 확대, 고령자 증가, 병용요법에 대한 수요 고조, 맞춤형 의료 성장, 보험 적용 확대 등에 기인할 것으로 보입니다. 이 기간에 예상되는 주요 동향으로는 약물 전달의 기술적 발전, 지속적인 연구개발, 표적요법의 혁신, 신규 알킬화제 개발, 종양학에서의 인공지능의 통합 등이 있습니다.
암의 유병률 상승은 향후 수년간 알킬화제 시장의 성장을 견인할 것으로 예측됩니다. 암은 건강한 조직에 침입하거나 파괴하는 이상 세포의 제어할 수 없는 증식 및 확산을 특징으로 하며, 거의 모든 장기나 조직에서 개발될 수 있으며, 혈액이나 림프계를 통해 퍼집니다. 암의 이환율이 증가하고 있는 것은 인구의 고령화가 주요 원인입니다. 위험 인자에 장기간 노출되고 유전적 변이가 장기간에 걸쳐 축적되면서 암 개발 위험이 나이가 들면서 현저하게 상승하기 때문입니다. 알킬화제는 암세포 DNA에 알킬기를 결합시켜 암을 치료하고 암세포 복제능력을 파괴해 암세포를 사멸시키고 종양 성장을 지연시킵니다. 예를 들어 2024년 10월 영국 국민보건서비스(NHS)는 2022년 새롭게 34만 6,217명의 암 환자가 진단돼 하루 평균 948명이었다고 보고했습니다. 그 결과 암 유병률 증가가 알킬화제 시장의 확대에 박차를 가하고 있습니다.
알킬화제 시장의 주요 기업은 다양한 건강 관리 환경에서 운반 및 사용 편의성을 향상시키는 주사용 화학요법제와 같은 혁신적인 제품 개발에 주력하고 있습니다. 주사용 화학요법제는 정맥 내 또는 주사를 통해 투여되는 약제로, 암과 싸우는 화합물을 혈류 또는 조직에 직접 전달하여 신속한 흡수 및 표적 종양 치료를 실현합니다. 예를 들면, 2024년 1월, 미국의 제약 제조업체 Avenacy Inc.는, 화학 요법에 사용되는 알킬화제로 알려진 멜파란염산염을 발매했습니다. 이 제품은 동결건조 멜팔란 50mg 바이알과 멸균희석액 10mL 바이알로 실온보존이 가능하도록 배합돼 수송성과 임상 접근성을 높였습니다. 또한 멜파란염산염은 정확한 약제 선택을 보장하기 위해 자체 포장과 라벨을 채택하고 있으며, 알켈란 주사용과 동등한 치료용 제네릭으로서 특히 경구 요법이 부적당한 경우 다발성 골수종 환자의 완화 치료에 적응하고 있습니다.
목차
제1장 주요 요약
제2장 시장 특징
제3장 시장 동향 및 전략
제4장 시장 : 금리, 인플레이션, 지정학, 무역전쟁 및 관세, 코로나 및 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오
제5장 세계의 성장 분석 및 전략 분석 프레임워크
세계의 알킬화제 : PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인 및 억제요인)
최종 이용 산업의 분석
세계의 알킬화제 시장 : 성장률 분석
세계의 알킬화제 시장 실적 : 규모 및 성장(2019-2024년)
세계의 알킬화제 시장 예측 : 규모 및 성장(2024-2029년, 2034년)
세계의 알킬화제 : 전체 시장 규모(TAM)
제6장 시장 세분화
세계의 알킬화제 시장 : 유형별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
머스타드 질소
니트로소우레아
아지리딘
에틸렌이민
트리아진
알킬술폰산염
세계의 알킬화제 시장 : 투여 경로별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
경구
정맥내
기타
세계의 알킬화제 시장 : 용도별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
종양학
혈액학
기타
세계의 알킬화제 시장 : 최종 사용자별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
병원
전문 클리닉
재택치료
기타
세계의 알킬화제 시장 : 머스타드 질소별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
메크로레타민
시클로포스파미드
이호스파미드
멜파란
클로람부실
세계의 알킬화제 시장 : 니트로소우레아별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
칼무스틴
롬스틴
스트렙토조신
셈스틴
세계의 알킬화제 시장 : 아지리딘별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
치오테파
마이토마이신 C
세계의 알킬화제 시장 : 에틸렌이민별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
헥사메틸멜라민(HMM)
알트레타민
세계의 알킬화제 시장 : 트리아진별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
다카르바진
테모졸로미드
세계의 알킬화제 시장 : 알킬술폰산염별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
부술팬
머스타드 유황
제7장 지역별 및 국가별 분석
세계의 알킬화제 시장 : 지역별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
세계의 알킬화제 시장 : 국가별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
제8장 아시아태평양 시장
제9장 중국 시장
제10장 인도 시장
제11장 일본 시장
제12장 호주 시장
제13장 인도네시아 시장
제14장 한국 시장
제15장 서유럽 시장
제16장 영국 시장
제17장 독일 시장
제18장 프랑스 시장
제19장 이탈리아 시장
제20장 스페인 시장
제21장 동유럽 시장
제22장 러시아 시장
제23장 북미 시장
제24장 미국 시장
제25장 캐나다 시장
제26장 남미 시장
제27장 브라질 시장
제28장 중동 시장
제29장 아프리카 시장
제30장 경쟁 구도 및 기업 프로파일
알킬화제 시장 : 경쟁 구도
알킬화제 시장 : 기업 프로파일
Pfizer Inc.
Merck KGaA
AstraZeneca PLC
Novartis AG
Fresenius Kabi AG
제31장 기타 주요 기업 및 혁신 기업
Teva Pharmaceuticals USA Inc.
Baxter Healthcare Corporation
Apotex Inc.
Jiangsu Hengrui Pharmaceuticals Co. Ltd.
Dr. Reddy's Laboratories Ltd.
Hikma Pharmaceuticals PLC
Cipla Limited
Aspen Pharmacare Holdings Limited
Zydus Lifesciences Limited
Emcure Pharmaceuticals Ltd.
KRKA dd Novo mesto
Sagent Pharmaceuticals Inc.
Debiopharm International SA
Accord Healthcare Ltd.
NextSource BIoTechnology LLC
제32장 세계 시장 경쟁 벤치마킹 및 대시보드
제33장 주요 인수합병(M&A)
제34장 최근 시장 동향
제35장 시장의 잠재력이 높은 국가, 부문 및 전략
알킬화제 시장(2029년) : 새로운 기회를 제공하는 국가
알킬화제 시장(2029년) : 새로운 기회를 제공하는 부문
알킬화제 시장(2029년) : 성장 전략
시장 동향에 의한 전략
경쟁 전략
제36장 부록
AJY
영문 목차
영문목차
Alkylating agents are a group of highly reactive chemical compounds that function by transferring alkyl groups (consisting of carbon and hydrogen atoms) to DNA molecules. This action disrupts the DNA's structure and function, ultimately hindering cell replication and causing cell death.
The primary types of alkylating agents include nitrogen mustards, nitrosoureas, aziridines, ethylenimines, triazines, and alkyl sulfonates. Nitrogen mustards are chemotherapy alkylating agents that interfere with cancer cell DNA replication by attaching alkyl groups, resulting in cell death. They can be administered via various routes, including oral and intravenous methods, and are applied in fields such as oncology and hematology. These agents are used by a range of end users, including hospitals, specialty clinics, homecare providers, and others.
The alkylating agents market research report is one of a series of new reports from The Business Research Company that provides alkylating agents market statistics, including the alkylating agents industry global market size, regional shares, competitors with the alkylating agents market share, detailed alkylating agents market segments, market trends, and opportunities, and any further data you may need to thrive in the alkylating agents industry. These alkylating agents market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.
The alkylating agents market size has grown strongly in recent years. It will grow from $5.06 billion in 2024 to $5.34 billion in 2025 at a compound annual growth rate (CAGR) of 5.6%. The growth during the historic period can be attributed to the early adoption of chemotherapy, increased healthcare spending, limited availability of alternative treatments, regulatory approvals, and the expansion of hospital infrastructure.
The alkylating agents market size is expected to see strong growth in the next few years. It will grow to $6.57 billion in 2029 at a compound annual growth rate (CAGR) of 5.3%. The growth in the forecast period can be attributed to the expanding oncology pipeline, an increasing geriatric population, rising demand for combination therapies, growth in personalized medicine, and broader insurance coverage. Key trends expected during this period include technological advancements in drug delivery, continuous research and development, innovations in targeted therapies, the development of new alkylating compounds, and the integration of artificial intelligence in oncology.
The rising prevalence of cancer is expected to drive the growth of the alkylating agents market in the coming years. Cancer is characterized by the uncontrolled growth and spread of abnormal cells that can invade or destroy healthy tissue, potentially developing in nearly any organ or tissue and spreading through the blood and lymphatic systems. The increasing incidence of cancer is largely attributed to aging populations, as the risk of developing cancer rises significantly with age due to prolonged exposure to risk factors and the accumulation of genetic mutations over time. Alkylating agents treat cancer by attaching alkyl groups to the DNA of cancer cells, disrupting their ability to replicate, leading to cancer cell death and slowing tumor growth. For example, in October 2024, the National Health Service (NHS) of the UK reported that 346,217 new cancer cases were diagnosed in 2022, averaging 948 cases per day-a 5% increase from the 329,664 cases recorded in 2021. Consequently, the growing prevalence of cancer is fueling the expansion of the alkylating agents market.
Leading companies in the alkylating agents market are focusing on developing innovative products such as injectable chemotherapeutic agents that improve transportability and ease of use across various healthcare environments. Injectable chemotherapeutic agents are drugs administered intravenously or by injection, delivering cancer-fighting compounds directly into the bloodstream or tissues for rapid absorption and targeted tumor treatment. For example, in January 2024, Avenacy Inc., a US-based pharmaceutical manufacturer, launched Melphalan Hydrochloride, a well-known alkylating agent used in chemotherapy. This product comes as a 50 mg vial of lyophilized melphalan and a 10 mL vial of sterile diluent, formulated for room-temperature storage to enhance transportability and clinical accessibility. Melphalan Hydrochloride also features proprietary packaging and labeling to ensure accurate medication selection and serves as a therapeutic equivalent generic to Alkeran for Injection, specifically indicated for palliative treatment of multiple myeloma patients when oral therapy is unsuitable.
In June 2024, Dr. Reddy's Laboratories Limited, an India-based pharmaceutical company, partnered with Ingenus Pharmaceuticals, LLC, a US-based pharmaceutical firm, to commercialize Cyclophosphamide injection. Through this collaboration, both companies aim to enhance their presence in the US oncology market by increasing the availability of Cyclophosphamide injection for cancer treatment. Ingenus Pharmaceuticals LLC specializes in injectable and complex generic pharmaceutical products across critical therapeutic areas, including oncology.
Major players in the alkylating agents market are Pfizer Inc., Merck KGaA, AstraZeneca PLC, Novartis AG, Fresenius Kabi AG, Teva Pharmaceuticals USA Inc., Baxter Healthcare Corporation, Apotex Inc., Jiangsu Hengrui Pharmaceuticals Co. Ltd., Dr. Reddy's Laboratories Ltd., Hikma Pharmaceuticals PLC, Cipla Limited, Aspen Pharmacare Holdings Limited, Zydus Lifesciences Limited, Emcure Pharmaceuticals Ltd., KRKA d. d. Novo mesto, Sagent Pharmaceuticals Inc., Debiopharm International SA, Accord Healthcare Ltd., NextSource Biotechnology LLC.
North America was the largest region in the alkylating agents market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in alkylating agents report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the alkylating agents market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The alkylating agents market consists of sales of aziridines, hydrazines, ethylenimines, methylmelamines and ifosfamide. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified.)
The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Alkylating Agents Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on alkylating agents market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for alkylating agents ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The alkylating agents market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.
Table of Contents
1. Executive Summary
2. Alkylating Agents Market Characteristics
3. Alkylating Agents Market Trends And Strategies
4. Alkylating Agents Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market
5. Global Alkylating Agents Growth Analysis And Strategic Analysis Framework
5.1. Global Alkylating Agents PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Alkylating Agents Market Growth Rate Analysis
5.4. Global Alkylating Agents Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Alkylating Agents Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Alkylating Agents Total Addressable Market (TAM)
6. Alkylating Agents Market Segmentation
6.1. Global Alkylating Agents Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Nitrogen Mustards
Nitrosoureas
Aziridines
Ethylenimines
Triazines
Alkyl Sulfonates
6.2. Global Alkylating Agents Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Oral
Intravenous
Other Route Of Administrations
6.3. Global Alkylating Agents Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Oncology
Hematology
Other Applications
6.4. Global Alkylating Agents Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospitals
Specialty Clinics
Homecare
Other End-Users
6.5. Global Alkylating Agents Market, Sub-Segmentation Of Nitrogen Mustards, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Mechlorethamine
Cyclophosphamide
Ifosfamide
Melphalan
Chlorambucil
6.6. Global Alkylating Agents Market, Sub-Segmentation Of Nitrosoureas, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Carmustine
Lomustine
Streptozocin
Semustine
6.7. Global Alkylating Agents Market, Sub-Segmentation Of Aziridines, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Thiotepa
Mitomycin C
6.8. Global Alkylating Agents Market, Sub-Segmentation Of Ethylenimines, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hexamethylmelamine (HMM)
Altretamine
6.9. Global Alkylating Agents Market, Sub-Segmentation Of Triazines, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Dacarbazine
Temozolomide
6.10. Global Alkylating Agents Market, Sub-Segmentation Of Alkyl Sulfonates, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Busulfan
Sulfur Mustard
7. Alkylating Agents Market Regional And Country Analysis
7.1. Global Alkylating Agents Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Alkylating Agents Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
